Search research articles
Contact Us
Filters
Showing results (191-200 of 340) with videos related to
Page
of 34
Sort By:
Journal of Crohn'S & Colitis
|
October 18, 2018
Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis
Fernando Magro, Cláudia Camila Dias, Francisco Portela, et al.
The Lancet. Gastroenterology & Hepatology
|
April 9, 2022
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey
Tommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Therapeutic Advances in Gastroenterology
|
December 7, 2020
Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
Cátia Rocha, Paula Lago, Samuel Fernandes, et al.
Inflammatory Bowel Diseases
|
April 4, 2026
Transmural improvement may be an acceptable target in patients with Crohns disease
Samuel Raimundo Fernandes, Sérgio Bronze, Inês Coelho Rodrigues, et al.
Journal of Crohn'S & Colitis
|
February 17, 2024
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus
Massimo Claudio Fantini, Gionata Fiorino, Agostino Colli, et al.
Microorganisms
|
June 28, 2023
Viable <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients
Maria Manuela Estevinho, José Cabeda, Mafalda Santiago, et al.
Plos One
|
February 23, 2017
The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis
Cláudia Camila Dias, Pedro Pereira Rodrigues, Samuel Fernandes, et al.
Journal of Crohn'S & Colitis
|
April 16, 2013
Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population
Cândida Abreu, Fernando Magro, João Santos-Antunes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 22, 2023
Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial
Fernando Magro, Marijana Protic, Gert De Hertogh, et al.
Inflammatory Bowel Diseases
|
June 25, 2025
Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched Analysis
Samuel Raimundo Fernandes, Inês Coelho Rodrigues, André Da Silva Neves, et al.
Page
of 34
Search research articles
Search
Showing results (191-200 of 340) with videos related to
Sort By:
Page
of 34
Journal of Crohn'S & Colitis
|
October 18, 2018
Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis
Fernando Magro, Cláudia Camila Dias, Francisco Portela, et al.
The Lancet. Gastroenterology & Hepatology
|
April 9, 2022
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey
Tommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Therapeutic Advances in Gastroenterology
|
December 7, 2020
Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
Cátia Rocha, Paula Lago, Samuel Fernandes, et al.
Inflammatory Bowel Diseases
|
April 4, 2026
Transmural improvement may be an acceptable target in patients with Crohns disease
Samuel Raimundo Fernandes, Sérgio Bronze, Inês Coelho Rodrigues, et al.
Journal of Crohn'S & Colitis
|
February 17, 2024
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus
Massimo Claudio Fantini, Gionata Fiorino, Agostino Colli, et al.
Microorganisms
|
June 28, 2023
Viable <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients
Maria Manuela Estevinho, José Cabeda, Mafalda Santiago, et al.
Plos One
|
February 23, 2017
The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis
Cláudia Camila Dias, Pedro Pereira Rodrigues, Samuel Fernandes, et al.
Journal of Crohn'S & Colitis
|
April 16, 2013
Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population
Cândida Abreu, Fernando Magro, João Santos-Antunes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 22, 2023
Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial
Fernando Magro, Marijana Protic, Gert De Hertogh, et al.
Inflammatory Bowel Diseases
|
June 25, 2025
Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched Analysis
Samuel Raimundo Fernandes, Inês Coelho Rodrigues, André Da Silva Neves, et al.
Page
of 34